Tendon Drug Bapten Removed From Market

  • Print
  • Email
  • Favorite
  • Share
  • Newsletters

Bapten, a medication that has shown promise in the treatment of bowed tendons, has been taken off the market because of reports of a troubling side effect. A prepared statement from Boehringer Ingelheim, the pharmaceutical company that distributes the drug, described the suspension of sales as "temporary."

According to the statement, the

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners